SEER Stock Analysis: Buy, Sell, or Hold?
SEER - Seer, Inc. Class A Common Stock
$2.17
-0.03 (-1.36%)
βΌ
5d:
+33.95%
30d:
+28.4%
90d:
+28.4%
WAIT
LOW Confidence
Analysis Updated: Jul 10, 2026 12:00 AM ET
Earnings: Aug 05, 2026
22d
Get Alerted When SEER Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
5 traders called SEER this week
100% bullish • 0 bearish
100% bullish • 0 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
βΈοΈ WAIT FOR BETTER ENTRY: SEER is 11.3% above its trading range ($1.95). While momentum could continue, risk/reward favors waiting for a pullback.
βΈοΈ WAIT FOR BETTER ENTRY: SEER is 11.3% above its trading range ($1.95). While momentum could continue, risk/reward favors waiting for a pullback.
In-depth Analysis How we analyze
Valuation Analysis: SEER is currently trading at $2.17, which is considered extended relative to its 30-day fair value range of $1.62 to $1.95.
Technical Outlook: Technically, SEER is showing sideways momentum. The price is approaching resistance at $1.93. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $4.00 (+84.3%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, SEER is showing sideways momentum. The price is approaching resistance at $1.93. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $4.00 (+84.3%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$1.62 -
$1.95
Company Quality Score
57/100
(HOLD)
Volume Confirmation
MODERATE
Confidence Score
35.3%
All Signals
- BEARISH: Price significantly overextended (+11.3% above its trading range)
- NEUTRAL: Mixed technical signals (45/100)
- BULLISH: Trading 84.3% below Wall St target ($4.00)
Trading Range Analysis
30-Day Trading Range
$1.62 -
$1.95
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$1.69
Resistance Level
$1.93
Current Trend
Sideways
Technical data as of
Jun 9, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-2.21
Wall Street Target
$4.00
(+84.3%)
Revenue Growth (YoY)
-33.6%
Share & Embed Analysis
Last updated: July 13, 2026 6:14 AM ET
Data refreshes hourly during market hours. Next update: 7:14 AM
Data refreshes hourly during market hours. Next update: 7:14 AM
π₯ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is SEER showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BMRN
Biomarin Pharmaceutical β¦ |
STRONG BUY
29 analysts |
$88 | 64 BUY |
|
LEGN
Legend BiotechΒ Corp |
STRONG BUY
22 analysts |
$57 | 52 HOLD |
|
DNLI
Denali Therapeutics Inc |
STRONG BUY
19 analysts |
$34 | 63 BUY |
|
AXSM
Axsome Therapeutics Inc |
STRONG BUY
19 analysts |
$277 | 60 HOLD |
|
MRUS
Merus BV |
STRONG BUY
17 analysts |
$97 | 55 HOLD |